RH
Exceptional purity for peptide research
We've been sourcing research-grade peptides for several years. Rainbow Peptide's vials consistently pass our HPLC verification, purity exceeds 98% every batch. COA matched our internal testing exactly.
HPLC Verified
>98% Purity
COA Included
SOMA Recovery & Tissue Repair
Orforglipron Capsules
$319.99
Orforglipron oral non-peptide GLP-1 receptor agonist in capsule format. Small-molecule metabolic signaling research compound with Phase III ATTAIN-DM weight loss data. COA included.
| Format | Capsule |
|---|---|
| Dosage | See COA / 30 capsules |
| Purity | >98% |
In Stock, Overnight and 2–3 day delivery available
Product Information
Orforglipron Capsules: Non-Peptide Oral GLP-1 Agonist for Metabolic Research
Orforglipron (LY3502970) is an orally active, non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly. Unlike peptide-based GLP-1 agonists (semaglutide, liraglutide), orforglipron does not require syringe administration and is stable at room temperature. Phase III ATTAIN-DM trial data demonstrated up to 16.2% weight loss at 36 weeks. These capsules enable research into non-peptide GLP-1R activation mechanisms and oral versus injectable pharmacodynamic comparisons.
Mechanism of Action
- GLP-1R agonism (non-peptide): binds the GLP-1 receptor orthosteric site as a small molecule, mimicking the actions of native GLP-1 without peptide structure
- Insulin secretion enhancement: glucose-dependent stimulation of pancreatic beta cells, reducing hypoglycaemia risk
- Appetite suppression: activates hypothalamic GLP-1R expressing neurons to reduce food intake
- Gastric emptying delay: slows gastric transit to reduce post-prandial glucose excursions
Research Areas
Orforglipron is studied in obesity, type 2 diabetes, NAFLD, and the comparative pharmacology of peptide vs. non-peptide GLP-1R agonists. Compare with Retatrutide vials (triple agonist) and Tirzepatide capsules (dual agonist) for comprehensive GLP-1R pathway research.
Typical Capsule Dosing in This Category
Non-peptide oral GLP-1 agonist capsule products across the research-chemical market, including orforglipron, are commonly formulated in the 6mg to 12mg per capsule range. Confirm the specific milligram content of any batch via its Certificate of Analysis before beginning a research protocol; capsule count alone does not indicate potency.
Independent Lab Verification
Rainbow Peptide works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.
For Research Use Only. Rainbow Peptide supplies this compound exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.
Frequently Asked Questions
- What is Orforglipron Capsules?
- Orforglipron oral non-peptide GLP-1 receptor agonist in capsule format. Small-molecule metabolic signaling research compound with Phase III ATTAIN-DM weight loss data. COA included.
- Is Orforglipron Capsules for sale at Rainbow Peptide?
- Yes. Orforglipron Capsules is available for purchase with Certificate of Analysis confirming >98% HPLC purity. Every order Overnight and 2–3 day delivery available. For Research Use Only.
- What purity is your Orforglipron Capsules?
- Rainbow Peptide's Orforglipron Capsules is >98% pure, HPLC verified through independent third-party laboratory testing, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01). A COA is included with every order.
- What does the Certificate of Analysis actually verify?
- A COA reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). Together, this verifies a batch matches its labeled specification, rather than relying on a purity claim alone.
- Is Orforglipron Capsules safe for human use?
- No. Orforglipron Capsules is strictly For Research Use Only (RUO). It is not intended for human consumption and is not intended to diagnose, treat, cure, or prevent any disease.
- How quickly does Orforglipron Capsules ship?
- Overnight and 2–3 day delivery available. Ships in temperature-controlled packaging.
Third-Party Verified
Every Order Ships with a Certificate of Analysis
We don't just claim purity, we prove it. Every batch of Orforglipron Capsules is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.
- HPLC purity analysis, minimum threshold >98%
- Mass spectrometry, molecular weight confirmation
- Lot number traceable to your order
- Endotoxin limits verified, safe for cell-based assays
RAINBOW PEPTIDE LABS CERTIFICATE OF ANALYSIS
Product Orforglipron Capsules
Lot # RP-00261-A
HPLC Purity >98.0% >98.5% PASS
Mass Spec (MW) Confirmed Confirmed PASS
Endotoxin <1 EU/mg <0.5 EU/mg PASS
Visual Inspection White powder White powder PASS
What Researchers Say
Verified purchases from active research labs and scientists
5.00
★★★★★
2 verified reviews MT
Reliable consistency batch to batch
Third order now. Consistent batch-to-batch results matter enormously in long-term research. Certificate of Analysis is detailed with mass spec data. Would not switch sources.
SK
Solid product, shipping was fast
Verified against our reference standards. Purity >98.2% by HPLC. Packaging was appropriate for temperature-sensitive peptides. Will re-order.
